Hualan Biological EngineeringInc Cash Flow-to-Debt Ratio
Hualan Biological EngineeringInc cash flow-to-debt ratio. Hualan Biological EngineeringInc (002007) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥319.46 Million could theoretically repay 0% of its total liabilities (CN¥3.02 Billion) in one year. Check Hualan Biological EngineeringInc (002007) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hualan Biological EngineeringInc (2003–2024)
Cash flow-to-debt ratio of Hualan Biological EngineeringInc from 2003 to 2024. Historical debt coverage capacity for Hualan Biological EngineeringInc across 22 annual periods. Check how aggressively does Hualan Biological EngineeringInc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Hualan Biological EngineeringInc Cash Flow-to-Debt Ratio by Year (2003–2024)
Hualan Biological EngineeringInc cash flow-to-debt ratio by year from 2003 to 2024. Year-by-year debt coverage analysis for Hualan Biological EngineeringInc. For the full cash flow conversion analysis, see Hualan Biological EngineeringInc (002007) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.43x | CN¥1.06 Billion | CN¥2.46 Billion | ▼ -14.2% |
| 2023 | 0.50x | CN¥1.35 Billion | CN¥2.68 Billion | ▲ +32.5% |
| 2022 | 0.38x | CN¥957.31 Million | CN¥2.53 Billion | ▼ -34.7% |
| 2021 | 0.58x | CN¥1.43 Billion | CN¥2.47 Billion | ▼ -15.3% |
| 2020 | 0.68x | CN¥1.33 Billion | CN¥1.94 Billion | ▼ -64.9% |
| 2019 | 1.95x | CN¥1.36 Billion | CN¥699.26 Million | ▲ +8.6% |
| 2018 | 1.79x | CN¥1.29 Billion | CN¥720.47 Million | ▲ +281.5% |
| 2017 | 0.47x | CN¥177.42 Million | CN¥377.24 Million | ▼ -69.3% |
| 2016 | 1.53x | CN¥329.94 Million | CN¥215.05 Million | ▼ -61.7% |
| 2015 | 4.00x | CN¥548.62 Million | CN¥137.11 Million | ▲ +7.6% |
| 2014 | 3.72x | CN¥497.15 Million | CN¥133.70 Million | ▲ +142.1% |
| 2013 | 1.54x | CN¥510.70 Million | CN¥332.55 Million | ▼ -59.1% |
| 2012 | 3.75x | CN¥494.69 Million | CN¥131.84 Million | ▲ +72.0% |
| 2011 | 2.18x | CN¥335.93 Million | CN¥153.99 Million | ▼ -39.1% |
| 2010 | 3.58x | CN¥609.53 Million | CN¥170.06 Million | ▼ -8.2% |
| 2009 | 3.90x | CN¥607.73 Million | CN¥155.67 Million | ▲ +184.6% |
| 2008 | 1.37x | CN¥161.18 Million | CN¥117.50 Million | ▲ +121.1% |
| 2007 | 0.62x | CN¥179.02 Million | CN¥288.51 Million | ▲ +7.5% |
| 2006 | 0.58x | CN¥131.43 Million | CN¥227.67 Million | ▼ -12.3% |
| 2005 | 0.66x | CN¥98.24 Million | CN¥149.20 Million | ▲ +340.0% |
| 2004 | 0.15x | CN¥21.48 Million | CN¥143.53 Million | ▲ +878.5% |
| 2003 | 0.02x | CN¥3.35 Million | CN¥218.79 Million | — |